Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos

Clinical trial NCT02543086 · TERMINATED

Trial details

NCT number: NCT02543086
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasmodium Falciparum Malaria

Start date: 2015-07-01
Primary completion: 2015-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.